Abstract
Objective
To evaluate to the efficacy and safety of Shenqi Fuzheng Injection (参芪扶正注射液, SFI) combined with chemotherapy in the treatment of acute leukemia (AL) by meta-analysis.
Methods
PubMed, Cochrane library, Embase, SinoMed, China National Knowledge Infrastructure (CNKI), VIP Journal Integration Platform, Wanfang Database were searched from establishment to November 1, 2018. The randomized controlled trials (RCTs) of SFI combined with chemotherapy in the treatment of AL were included. The Cochrane risk assessment form (RevMan 5.1) was used to evaluate the quality of included studies.
Results
A total of 14 RCTs and 1,088 patients was included. The quality evaluation were mostly low risk or unclear. Meta-analysis showed that compared with chemotherapy alone, SFI combined with chemotherapy can improve the total clinical effective rate in patients with AL (RR=1.15, 95% CI: 1.056–1.177; P=0.0001), and relieve adverse reactions caused by chemotherapy drugs, including infection (RR=0.561, 95% CI: 0.397–0.792; P=0.001), nausea and vomiting (RR=0.662, 95% CI: 0.524–0.835; P=0.001), bleeding (RR=0.548, 95% CI: 0.39–0.768; P=0.0001), cardiotoxicity (RR=0.230, 95% CI: 0.080–0.660; P=0.006) and hyperhidrosis (RR=0.348, 95% CI: 0.208–0.581; P=0.0001). The incidence rates of adverse reactions in SFI combined with chemotherapy group were significantly lower than that of the chemotherapy alone group (P<0.01).
Conclusions
Shenqi Fuzheng Injection combined with chemotherapy has good efficacy and safety for AL, and it can alleviate the adverse reactions caused by chemotherapy. However, subject to the limitations of the methodological quality of the literature, the conclusions of this study need to be further verified by large-scale and multi-center RCTs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Xia YZ, Chen Y, Wang Z. Effect of Shenqi Fuzheng Injection combined with thalidomide on the proportion of peripheral blood regulatory T cells in acute myeloid leukemia. Chin J Tradit Chin Med (Chin) 2016;34:1215–1217.
Li H, He M, Li LG, et al. Effects of Shenqi Fuzheng Injection combined with decitabine on serum HGF, VEGF and LDH levels in patients with acute myeloid leukemia. Prog Modern Biomed 2018;18:3400–3403.
Chen SZ, Qi XM, Qian DY, et al. Clinical observation of Shenqi Fuzheng Injection in preventing cardiotoxicity of anthracyclines. J Pract Clin Med 2017;21:163–164.
Chen KH, Yeh MH, Livneh H, et al. Association of traditional Chinese medicine therapy and the risk of dementia in patients with hypertension: a nationwide population-based cohort study. BMC Complement Altern Med 2017;17:178–183.
Zhou WD, Xiang L, Lu HQ. Experimental study on the improvement of 5-fluorouracil-induced small intestinal mucositis by Codonopsis pilosula polysaccharides. Liaoning J Tradit Chin Med (Chin) 2016;43:1495–1497.
Zeng D, Huang ZY, Su DY. Effects of Codonopsis pilosula extract on reproductive performance and blood parameters of sows. Feed Res 2016;13:31–34.
Wang WJ. Feasibility study of Shenqi Fuzheng Injection combined with chemotherapy for lung cancer treatment. J Mathematical Med 2019;32:102–103.
Hu BY, Yang XY, Sun YC. Clinical observation of Shenqi Fuzheng Injection combined with CAF chemotherapy in the treatment of breast cancer. Chin J Tradit Chin Med (Chin) 2018;36:2778–2780.
Xiao D, Zhang HZ, Zuo XH. Effect of Shenqi Fuzheng Injection on heart failure after acute myocardial infarction in the elderly. J Integr Tradit West Med Card Cerebr Dis (Chin) 2016;14:106–110.
Chai HY. Effect of Shenqi Fuzheng Injection on bone marrow hematopoietic function and immune function in patients with acute lymphocytic leukemia. Bengbu Med Coll (Chin) 2017;42:1356–1362.
Jia JW, Liu YQ. Treatment of advanced gastric cancer with Shenqi Fuzheng Injection combined with FOLFOX4 regimen observation of the curative effect of cancer. J Pract Cancer (Chin) 2009;24:275–281.
Chen ZC, Wang HX, Swimming S, et, al. Effect of Shenqi Fuzheng Injection on dendritic cells in patients with acute myeloid leukemia in vitro. J Clin Intern Med (Chin) 2007;24:455–459.
Zhang H, Chen T, Shang L. ShenQi FuZheng Injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis. Pharmaceutical Biol 2019;57:612–624.
Wu JH, Xie BC, Wang QH, Zhou CH, Xu DH. Systematic review of Shenqi Fuzheng Injection combined with chemotherapy for treatment of breast cancer. Chin J Chin Mater Med (Chin) 2019;44:589–596.
Zhang WQ, Zhang JH, Wu ZL, et al. Meta-analysis of Shenqi Fuzheng Injection combined with chemotherapy in treatment of colorectal cancer. Med Plant 2018;9:83–88.
Zhang ZN, ed. Blood disease diagnosis and efficacy criteria. 2nd version. Beijing: Science Press;1998:168.
Chinese Society of Integrated Traditional and Western Medicine Hematology Committee. Acute leukemia diagnosis and treatment routine. Wuhan: The 8th National Symposium on Integrated Traditional Chinese and Western Medicine Hematology Symposium; 2007:8.
Yao B, Zhang YL, Chen WL. Shenqi Fuzheng Injection for hematopoiesis and immunity in patients with acute lymphoblastic leukemia. Modern Biomed Prog (Chin) 2015;15:808–811.
Zhu XY, Zhang XZ, Zhong XY. Effects of Shenqi Fuzheng Injection on hematopoietic function and immune function in patients with hematologic malignancies. Chin J Integr Tradit Chin West Med (Chin) 2010;30:205–207.
Yang X, Xu ZL. The efficacy of Shenqi Fuzheng Injection combined with FLAG regimen in the treatment of refractory acute lymphoblastic leukemia and its effect on serum IFN-γ and IL-10. Modern J Integr Tradit Chin West Med (Chin) 2017;26:826–829.
Qian YH. Effect of Shenmao Fuzheng Injection combined with chemotherapy on telomerase activity of bone marrow cells in patients with acute leukemia [Dissertation]. Guangzhou: Guangzhou University of Traditional Chinese Medicine; 2009.
Chen FW, He HM. Effect of Shenqi Fuzheng Injection combined with chemotherapy on cellular immune function in patients with acute lymphocytic leukemia. Jilin Med J (Chin) 2018;39:1255–1257.
Wang P. Effect of Shenqi Fuzheng Injection combined with chemotherapy on cellular immune function in patients with acute lymphocytic leukemia. Med J Chin People’s Health (Chin) 2017;29:89–90.
Wu PQ, Yuan KF, Jing L. Effect of Shenqi Fuzheng Injection combined with chemotherapy on the efficacy and immune function of patients with acute myeloid leukemia. Chin Tradit Herb Drugs (Chin) 2015;46:401–404.
Yang XH, Chen J, Zhao HF. Effect of Shenqi Fuzheng Injection combined with chemotherapy on acute leukemia and its effects on T lymphocyte subsets, serum interferon-γ and interleukin. Eval Anal Drug-Use Hosp Chin (Chin) 2018;18:1200–1202.
Shi YR. Clinical effect of Shenqi Fuzheng Injection combined with chemotherapy on acute leukemia and its effect on the immune function of patients. Chin J Pract Med (Chin) 2017;44:114–117.
Fan XH. Clinical observation of Shenqi Fuzheng Injection combined with chemotherapy in the treatment of refractory relapse acute leukemia [Dissertation]. Hanzhou: Zhejiang University of Traditional Chinese Medicine; 2008.
Yu H, Yong F, Cao F. The efficacy of Shenqi Fuzheng Injection combined with chemotherapy in the treatment of hematological malignancies and its effects on hematopoiesis and immunity. World Chin Med (Chin) 2018;13:2136–2139.
Yao JH, Xia XJ. Therapeutic effect of Shenqi Fuzheng Injection combined with chemotherapy in the treatment of 38 cases of acute leukemia. J New Chin Med (Chin) 2007;39:77–78.
Wei YF, Wang SY, Ren LL. Effect of Shenqi Fuzheng Injection combined with chemotherapy on acute leukemia and T lymphocyte subsets and serum IFN-γ, IL-10, IL-2 level of influence. Chin J Integr Tradit West Med (Chin) 2005;25:303–306.
Liu HY. Fuzheng Peiben method exerts the detoxicating and tonifying effect on patients with acute leukemia undergoing chemotherapy. China Health Indust 2014;24:38–39.
Dong BY, Wang C, Tan L. Inhibitory effect of Shenqi Fuzheng Injection combined with docetaxel on lung cancer cells. J Zhejiang Univer (Chin) 2017;18:76–78.
Liao Q, Xing R. Progress in pharmacological action and clinical application of Shenqi Fuzheng Injection. Chin Pharm (Chin) 2016;24:3455–3456.
Xia YZ, Chen Y, Wang Z. Effect of Shenqi Fuzheng Injection combined with thalidomide on the proportion of peripheral blood regulatory T cells in acute myeloid leukemia. Chin J Tradit Chin Med (Chin) 2016;34:1215–1217.
Author information
Authors and Affiliations
Contributions
Meng FX designed this study and prepared the manuscript; Yang X and Meng FX researched literature and performed the data analysis, Li ML evaluated the quality of the included study.
Corresponding author
Additional information
Conflict of Interest
The authors have no conflicts of interests.
Supported by Science and Technology Fund Project of Health and Family Planning Commission of Guizhou Province (No. gzwjkj2019-2-006) and the Science and Technology Plan Project of Qiannan Prefecture [Qiannan Keheshezi (2018) No. 36]
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Meng, Fx., Yang, X. & Li, Ml. Shenqi Fuzheng Injection (参芪扶正注射液) Combined with Chemotherapy for Acute Leukemia: A Meta-Analysis. Chin. J. Integr. Med. 28, 81–87 (2022). https://doi.org/10.1007/s11655-020-3264-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-020-3264-7